NOTICE:

In 2010, Optherion completed two separate business transactions, one related to its diagnostics business and one related to its therapeutics business.

With respect to its diagnostics business, in February, 2010, Optherion completed an exclusive worldwide licensing agreement with Sequenom, Inc.. Under the agreement, Sequenom’s CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD). Please see News Room at Optherion.com for Sequenom’s press release.

With respect to its therapeutics business, also in 2010, Optherion completed a business transaction with another company. Both the company name and the transaction economics are confidential.

As a result of these two transactions, Optherion, itself, is no longer actively developing any diagnostics or therapeutics. Given this, the Optherion.com website has not been updated since year-end, 2010 albeit the nature of Optherion’s diagnostic and therapeutic endeavors are accurately represented in the website for the time period prior to the transactions.

Kindest regards,

Colin J. Foster
President & CEO
Optherion, Inc.

Optherion, Inc. Selected as the Edwards Angell Palmer & Dodge Award Winner By the Connecticut Technology Council. Also Recognized as One of 100 Technology “Companies to Watch”

SEPTEMBER 17, 2008: NORWALK, CT – Optherion, Inc. won the Edwards Angell Palmer & Dodge Award for most venture capital raised in the biotechnology sector at the second annual Innovation Pipeline Awards and technology showcase in front of over 350 guests at the Dolce Innovation Center. The Connecticut Technology Council, the state’s industry association for the technology sector, annually recognizes companies with sales under $10M, an innovative product and a business model that demonstrates potential for future success.

Optherion was also recognized as one of 100 technology “companies to watch” for 2008.

Matthew Nemerson, the CTC President and CEO, notes “we look at hundreds of new ideas and start-ups every year and the companies recognized here are the ones we feel are not only the most exciting but have a real chance to become fast growing new firms.”

Awards are the result of a nomination and judging process that engages dozens of technology leaders from corporations such as Pitney Bowes, GE, UTC and Open Solutions and firms such as law firms Cantor Colburn, LLP, Edwards Angell Palmer and Dodge, LLP and the accounting firm Fiondella, Milone, and Lasaracina.

Mr. Colin Foster, President & CEO of Optherion, Inc. said, “This is a great honor and it is wonderful to be recognized for the hard work and successes we have achieved. “